Kaiser Permanente Addiction Medicine

Kaiser Permanente Addiction Medicine - Los Angeles, CA

Kaiser Permanente Addiction Medicine is an addiction treatment center situated at 1505 North Edgemont Avenue in the 90027 zip code of Los Angeles, CA. It is run by a private non-profit organization. Kaiser Permanente Addiction Medicine offers naltrexone administration, prescribes suboxone and buprenorphine maintenance. Kaiser Permanente Addiction Medicine provides regular outpatient treatment, outpatient rehabilitation and outpatient methadone/buprenorphine or naltrexone treatment. Some of the treatment approaches used by Kaiser Permanente Addiction Medicine include brief intervention, motivational interviewing and relapse prevention treatment. It provides residential treatment for substance abuse.

Address: 1505 North Edgemont Avenue, Los Angeles, CA 90027

  1. Types of Care
  2. Service Settings
  3. Opioid Medications used in Treatment
  4. Type of Alcohol Use Disorder Treatment
  5. Type Of Treatment
  6. Pharmacotherapies
  7. Treatment Approaches
  8. Facility Ownership
  9. License/Certification/Accreditation
  10. Payment/Insurance/Funding Accepted
  11. Special Programs/ Population Groups Supported
  12. Assessment/Pre-treatment
  13. Screening & Testing
  14. Transitional Services
  15. Ancillary Services
  16. Counseling Services and Education
  17. Tobacco/Screening Services
  18. Facility Smoking Policy
  19. Age Groups Accepted
  20. Gender Accepted
  21. Services for deaf
  22. Additional Spoken Languages

Here are the full facility listing details on Kaiser Permanente Addiction Medicine in Los Angeles, CA:

Types of Care:

  • residential treatment for substance use

Service Settings:

  • outpatient rehabilitation
  • partial hospitalization
  • IOT
  • outpatient methadone/buprenorphine or naltrexone treatment
  • regular outpatient treatment

Opioid Medications used in Treatment:

  • Buprenorphine treatment
  • Naltrexone clinical treatment

Type of Alcohol Use Disorder Treatment:

  • Administers medication for alcohol use disorder

Type Of Treatment:

  • buprenorphine maintenance
  • suboxone prescription
  • administers naltrexone

Pharmacotherapies:

  • Acamprosate (Campral)
  • Disulfiram (Antabuse)
  • Buprenorphine with naloxone (Ex. Suboxone)
  • Naltrexone (oral)
  • Naltrexone (extended-release, injectable naltrexone - Vivitrol)
  • Medications for psychiatric disorders

Treatment Approaches:

  • anger management
  • brief intervention services
  • cognitive behavioral therapy
  • motivational interviewing
  • relapse prevention
  • substance use counseling approach
  • counseling for trauma victims
  • 12-step rehab

Facility Ownership:

  • a private non-profit organization

License/Certification/Accreditation:

  • Certified by the National Committee for Quality Assurance

Payment/Insurance/Funding Accepted:

  • Accepts private health insurance

Special Programs/ Population Groups Supported:

  • rehab for teenagers

Assessment/Pre-treatment:

  • Comprehensive substance use assessment

Screening & Testing:

  • Breathalyzer or blood alcohol testing
  • Drug or alcohol urine screening
  • Screening for substance use

Transitional Services:

  • Aftercare/continuing care
  • Discharge Planning
  • Naloxone and overdose education

Ancillary Services:

  • Case management
  • Mental health services

Counseling Services and Education:

  • counseling for individuals
  • counseling for groups
  • family counseling
  • marital/couples counseling
  • substance use education

Tobacco/Screening Services:

  • Nicotine replacement therapy
  • Non-nicotine smoking/tobacco cessation medications
  • Screening for tobacco use
  • Smoking/tobacco cessation counseling

Facility Smoking Policy:

  • Smoking not allowed

Age Groups Accepted:

  • accepts children under 18

Gender Accepted:

  • women
  • men

Services for deaf:

  • Services for the deaf and hard of hearing are available

Additional Spoken Languages:

  • Spanish

Phone #: 323-783-8206

Other inpatient treatment centers within 75 miles of Kaiser Permanente Addiction Medicine: